6 results
diagnosis sle druginduced erythematosus systemic treatment benefits comparison dil hcq hydroxychloroquine nephritis nephrology pharmacology risks sideeffects summary table
Systemic Lupus Erythematosus (SLE) - Diagnosis and Management Summary • Epidemiology: 10-180/100,000, Typically Age 20-40, F:M
Systemic Lupus Erythematosus ... Management Summary ... Manifestations: Malar ... , oral ulcers, Lupus ... #Summary #rheumatology
Management of Lupus Nephritis Lupus nephritis (LN) in 10 to 40% of SLE Hallmark = proteinuria 20.5 g/g
Management of Lupus ... Nephritis Lupus ... severity (ISN/RPS classification ... by 12 months Classification ... #rheumatology #
Drug Induced Lupus vs SLE Drug Induced Lupus (DIL): • Epidemiology: -10% of all lupus cases, drug-dependent,
& NPSLE rare, Malar ... Workup: - ANA ... Manifestations: Malar ... Workup: - ANA ... comparison #table #rheumatology
Hydroxychloroquine - Risks and Benefits in Lupus Benefits: ↓ Disease activity, ↓ Flare, ↓ Damage, ↓ Corticosteroid dose,
Benefits in Lupus ... very uncommon but should ... Risks #Benefits #Lupus ... #pharmacology #adverseeffects ... #sideeffects #rheumatology
SLE (Systemic Lupus Erythematosus) Suspect: Clinical evidence of (fatigue, rash, photosensitivity, inflammatory arthritis, weight loss, and fever) and
Skin Disease Classification ... Non-autoimmune rheumatologic ... Photosensitivity • Malar ... antibodies • (-) ANA ... Erythematosus #Diagnosis #Rheumatology
Drug Induced Lupus (DIL) • Epidemiology: -10% of all lupus cases, drug-dependent, 4:1 to 1:1 F:M
Drug Induced Lupus ... & NPSLE rare, Malar ... Workup: - ANA ... #DIL #rheumatology ... diagnosis #treatment #management
No results found for "Plasmodium malaria rheumatology lupus shoulder ana classification adverseeffects management"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Plasmodium #malaria #rheumatology #lupus #shoulder #ana #classification #adverseeffects #management